Report Detail
Drug Delivery: Injection Devices
Markets covered by this analysis include the US, Japan, the five major EU markets (France, Germany, Italy, Spain, and the UK), and the Rest of World (RoW) markets, which includes all other countries. Despite its relative invasiveness and technological maturity, instrument-based injection of pharmaceutical preparations is regarded as the most accurate, reproducible method of therapeutic drug and fluid delivery. The combined global market for injection DDT products totalled more than $5.4bn in 2016, and is expected to climb at a rate of 6.6% over the forecast period. The safety syringes market is expected to experience the most dollar sales ($3.1bn in 2016), as well as the greatest growth over the forecast period (9.4%). In the PICCs segment of the VADs market, factors including reduced infection risk, the ability to be placed by nurses, and reduced placement cost compared to CVCs and ports are driving growth, which is expected to progress at 5.7% over the forecast period. This analysis includes a discussion of products, current/forecast markets, competitors, and opportunities in the global needles/syringes (standard and safety) and VADs (short peripheral catheters, midline catheters, PICCs, CVCs, and implantable ports) markets.